GlucoTrack, Inc.
GCTK
$7.42
-$0.24-3.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.87M | 5.05M | 3.57M | 2.91M | 2.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.09M | 14.55M | 13.11M | 12.08M | 8.77M |
| Operating Income | -15.09M | -14.55M | -13.11M | -12.08M | -8.77M |
| Income Before Tax | -26.50M | -22.60M | -14.92M | -12.05M | -8.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.50 | -22.60 | -14.92 | -12.05 | -8.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.50M | -22.60M | -14.92M | -12.05M | -8.74M |
| EBIT | -15.09M | -14.55M | -13.11M | -12.08M | -8.77M |
| EBITDA | -15.05M | -14.51M | -13.08M | -12.05M | -8.75M |
| EPS Basic | -40.35 | -- | -- | -- | -- |
| Normalized Basic EPS | -25.22 | -- | -- | -- | -- |
| EPS Diluted | -40.35 | -- | -- | -- | -- |
| Normalized Diluted EPS | -25.22 | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 169.30K | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 169.30K | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |